1Irish JM,Kotecha N,Nolan GP. Mapping normal and cancer cell signalling networks:towards single-cell proteomics[J].Nature Reviews Cancer,2006,(02):146-155.doi:10.1038/nrc1804.
2Whitfield ML,George LK,Grant GD. Common markers of proliferation[J].Nature Reviews Cancer,2006,(02):99-106.doi:10.1038/nrc1802.
3Wasinger VC,Cordwell SJ,Cerpa-Poljak A. Progress with geneproduct mapping of the Mollicutes:Mycoplasma genitalium[J].Electrophoresis,1995,(07):1090-1094.
4Merchant M,Weinberger SR. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry[J].Electrophoresis,2000,(06):1164-1177.
5Petricoin EF,Liotta LA. Proteomic analysis at the bedside:early detection of cancer[J].Trends in Biotechnology,2002,(12 Suppl):S30-S34.
6Rui Z,Jian-Guo J,Yuan-Peng T. Use of serological proteomic methods to find biomarkers associated with breast cancer[J].Proteomics,2003,(04):433-439.
8van Winden AW,Gast MC,Beijnen JH. Validation of previously identified serum biomarkers for breast cancer with SELDITOF MS:a case control study[J].BMC Med Genomics,2009.4.doi:10.1186/1755-8794-2-4.
10Jacquemier J,Ginestier C,Rougemont J. Protein expression profiling identifies subclasses of breast cancer and predicts prognosis[J].Cancer Research,2005,(03):767-779.
3Engwegen JY, Gast MC, Schellens JH, et al. Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spee trometry[J]. Trends Pharmacol Sci, 2006, 27 (5): 251-259.
4Mathelin C, Tomasetto C, Cromer A, et al. Proteomics and breast cancer [J]. Gynecol Obstet Fertil, 2006, 34 (12):1161-1169.
5Li J, Zhang Z, Rosenzweig J, et al. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer [J] Clin Chem, 2002, 48 (8): 1296-1304.
6Merchant M, Weinberger SR. Recent advancements in surface-enhanced laser desorption/ionization-time of flightmass spectrometry [J]. Electrophoresis, 2000, 21(6) : 1164-1177.
7Smith RA, Cokkinides V, Eyre H J, et al. American Cancer Society guidelines for the early detection of cancer, 2004 [J]. CA Cancer J Clin, 2004, 54(1) : 41-52.
8Gion M, Mione R, Leon AE, et al. Comparison of the diagnostic accuracy of CA27.29 and CA15.3 in primary, breast cancer [J]. Clin Chem, 1999, 45(5): 630-637.
9Hou MF, Chen YL, Tseng TF, et al. Evaluation of serum CA27.29, CA15-3 and CEA in patients with breast cancer [J]. Kaohsiung J Med Sci, 1999, 15(9): 520-528.
10Li JN, Zhang Z, Rosenzweig J, et al. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer [J]. Clin Chem, 2002, 48(8): 1296-1304.
